Skip to main content

National Institutes of Health — Portfolio, Page 7

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

491
Companies
$1.9B
Total invested
$4.9M
Avg. check
39
Industries
Health Care 17Biotechnology 12Medical Device 7Medical 5Hospital 5Therapeutics 4+33 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 145–168 of 491
Biomotum
March 2025

Wearable rehabilitation robotics

Health Care · Portland$290K Seed
Dascena
March 2022

Dascena develops machine learning algorithms to enable early disease intervention and improve care outcomes for patients.

Big Data · HoustonGrant
AivoCode
March 2024

AivoCode is an emerging biotech focused on critical and highly prevalent diseases affecting the central nervous system

Biotechnology · San Diego$600K Grant
Myosin Therapeutics
March 2026

Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications for CNS-based disorders.

Biotechnology · Jupiter$2.0M Grant
Jigsawdio
March 2023

Jigsawdio is a women owned platform designed to help people with memory loss.

Gaming · Raleigh$500K Grant
MAIA Biotechnology
March 2026

MAIA Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies that target telomeres through immunotherapy.

Biotechnology · Chicago$30.0M Post-IPO Equity
Azitra
March 2026

Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.

Alternative Medicine · Branford$31.0M Post-IPO Equity
Amissa Health
March 2025

Amissa powers evidence-based perimenopause care with AI-enabled clinical decision support.

Analytics · Charlotte$75K Grant
Enspectra Health
March 2022

Enspectra Health is a digital transformation in pathology by imaging cellular anatomy.

Health Care · Menlo Park$1.2M Grant
Accure Health
March 2024

Accure Health develops AI-powered, biomarker-guided solutions that enable precision therapies delivered to the right patients, right cells.

Health Care · CambridgeNon-equity Assistance
OmniLife
March 2022

OmniLife is a health IT SaaS company providing care coordination, workflow, and integrated communication software for hospitals

Health Care · Lexington$1.0M Convertible Note
Amydis
March 2026

Amydis is a pharmaceutical company that focuses on developing innovative chemistry to detect diseases.

Biotechnology · San Diego$2.5M Grant
PETcoil
March 2025

PETcoil makes multimodality molecular imaging more accurate, sensitive, and affordable.

Biotechnology · Sunnyvale$4.1M Grant
Lightengale
February 2022

Lightengale develops medical devices for improved ICU infusion lines.

Health Care · Decatur$50K Grant
Behaivior
February 2024

Behaivior is a digital health company democratizing mental health recovery and wellness using AI, behavioral health tech, and wearables.

Artificial Intelligence (AI) · Pittsburgh$800K Grant
Mustang Bio
February 2025

Mustang Bio is a clinical-stage biopharmaceutical company .

Biotechnology · New York$8.0M Post-IPO Equity
Versiti
February 2026

Versiti provide innovative, value added solutions in the fields of transfusion medicine, transplantation, and blood-related diseases.

Biotechnology · Milwaukee$3.0M Grant
Sonomotion
February 2025

Sonomotion is a medical device manufacturing company that specializes in providing medical solutions for kidney stones disease.

Clinical Trials · South San Francisco$2.2M Grant
Autonomous Medical Devices
February 2024

Autonomous Medical Devices is a developer of a medical device designed to detect pathogens and viruses.

Biotechnology · Inglewood$5.3M Grant
Joyuus
February 2023

Joyuus is a women's health startup dedicated on creating easily accessible well-being for mothers.

Health Care · West Greenwich$1.7M Grant
Arc Bio LLC
February 2022

Arc Bio provides research and development in the physical, engineering, and life sciences.

Biotechnology · Menlo Park$1.9M Grant
Perspective Therapeutics
February 2026

Perspective Therapeutics focuses on advancing cancer treatments employing radiation, radiopharmaceuticals, and imaging technology.

Health Care · Seattle$175.0M Post-IPO Equity
Index HealthTech, LLC
February 2026

Behavioral Biomarker Infrastructure for aging adults — catching functional decline before it becomes a crisis.

Assistive Technology · Suffolk$10K Grant
Phase
February 2024

Phase provides 3D-printing medical devices for microfluidics.

3D Printing · Cornelius$1.8M Grant

Where National Institutes of Health invests

Health Care17
Biotechnology12
Medical Device7
Medical5
Hospital5
Therapeutics4

About National Institutes of Health's portfolio

How many companies has National Institutes of Health invested in?▸

National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does National Institutes of Health invest in?▸

National Institutes of Health's top investment sectors include Health Care, Biotechnology, Medical Device, Medical, Hospital. The firm invests across 39 different industry categories.

What is National Institutes of Health's largest investment?▸

Among tracked funding rounds, Perspective Therapeutics received $175.0M in a Post-IPO Equity round. National Institutes of Health's total known invested capital is $1.9B.

What is the average investment size for National Institutes of Health?▸

National Institutes of Health's average investment size is $4.9M across its portfolio of 491 companies.

What are National Institutes of Health's most recent investments?▸

Recent National Institutes of Health portfolio additions include Biomotum, Dascena, AivoCode, Myosin Therapeutics, Jigsawdio. These companies were founded in 2020 or later.

Reach the founders behind these 491 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →